These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 17509451)
1. Evaluation of immune regulation in transplant patients using the trans vivo delayed type hypersensitivity assay. Pelletier RP; Bickerstaff AA; Adams PW; Orosz CG Hum Immunol; 2007 Jun; 68(6):514-22. PubMed ID: 17509451 [TBL] [Abstract][Full Text] [Related]
2. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Pelletier RP; Hennessy PK; Adams PW; Orosz CG Am J Transplant; 2002 Nov; 2(10):926-33. PubMed ID: 12482144 [TBL] [Abstract][Full Text] [Related]
3. Human liver allograft acceptance and the "tolerance assay": in vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression. Geissler F; Jankowska-Gan E; DeVito-Haynes LD; Rhein T; Kalayoglu M; Sollinger HW; Burlingham WJ Transplantation; 2001 Aug; 72(4):571-80. PubMed ID: 11544414 [TBL] [Abstract][Full Text] [Related]
4. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis. Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098 [TBL] [Abstract][Full Text] [Related]
5. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Rodriguez DS; Jankowska-Gan E; Haynes LD; Leverson G; Munoz A; Heisey D; Sollinger HW; Burlingham WJ Am J Transplant; 2004 Apr; 4(4):537-43. PubMed ID: 15023145 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation. Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191 [TBL] [Abstract][Full Text] [Related]
7. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation. Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907 [TBL] [Abstract][Full Text] [Related]
8. Trans-vivo delayed type hypersensitivity assay for antigen specific regulation. Jankowska-Gan E; Hegde S; Burlingham WJ J Vis Exp; 2013 May; (75):e4454. PubMed ID: 23665523 [TBL] [Abstract][Full Text] [Related]
9. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR; Perry LL J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920 [TBL] [Abstract][Full Text] [Related]
10. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study. Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts. Cooper JE; Gralla J; Chan L; Wiseman AC Clin Transpl; 2011; ():359-64. PubMed ID: 22755431 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against MICA antigens and kidney-transplant rejection. Zou Y; Stastny P; Süsal C; Döhler B; Opelz G N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098 [TBL] [Abstract][Full Text] [Related]
13. Dependency of the trans vivo delayed type hypersensitivity response on the action of regulatory T cells: implications for monitoring transplant tolerance. Warnecke G; Chapman SJ; Bushell A; Hernandez-Fuentes M; Wood KJ Transplantation; 2007 Aug; 84(3):392-9. PubMed ID: 17700166 [TBL] [Abstract][Full Text] [Related]
14. Acute humoral rejection in a zero mismatch deceased donor renal transplant due to an antibody to an HLA-DP alpha. Singh P; Colombe BW; Francos GC; Martinez Cantarin MP; Frank AM Transplantation; 2010 Jul; 90(2):220-1. PubMed ID: 20644454 [No Abstract] [Full Text] [Related]
15. Evidence for a limited contribution of immune regulation to cardiac allograft acceptance. Bickerstaff A; Orosz C Hum Immunol; 2002 Oct; 63(10):935-47. PubMed ID: 12368046 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy. Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity. Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580 [TBL] [Abstract][Full Text] [Related]
18. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations. Youssef AR; Otley C; Mathieson PW; Smith RM Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767 [TBL] [Abstract][Full Text] [Related]